NICOYA年衍药业
/
← All feature readings
Feature articleAbout 6 min read

蛀牙牙周反复?别忽略骨化二醇的作用

蛀牙牙周反复?别忽略骨化二醇的作用

骨化二醇,即25(OH)D,是体内维生素D的主要储存形式,25(OH)D是否充足是维生素D是否缺乏的判断标准。维生素D经25-羟化酶催化合成25(OH)D,25(OH)D再经1α-羟化酶作用,成为1,25(OH)2D[1]。维生素D在口腔健康中受到越来越多的关注,通过1,25(OH)2D/VDR通路的抗炎、抗菌、免疫调节效应,参与维持口腔健康。无论是生长发育期,还是成年阶段,骨化二醇水平不足与多种口腔疾病相关,并且还可能加速部分口腔疾病的进展[2]。

维生素D缺乏影响牙周炎及牙周再生手术的潜在作用机制[2]

骨化二醇水平不足与牙齿矿化和龋齿

维生素D在骨骼与牙齿矿化中扮演关键角色,25(OH)D水平不足可导致“佝偻病牙”,即牙齿矿化发育缺陷、矿化不足,牙齿极易折裂、发生龋坏[3-4]。一项随机对照试验显示[5],孕期25(OH)D水平<15 ng/mL的孕妇,后代儿童乳牙发生病变的风险升高14%。另一项事后分析显示[6],相较于仅使用标准剂量的对照组,孕期接受大剂量维生素D补充的母亲,其子代恒牙发生牙釉质缺陷的风险更低(15.1% vs 27.5%),乳牙也观察到类似结果(8.6% vs 15.9%)。一项纳入2827名儿童临床试验的系统综述[7],探究补充维生素D对龋齿的预防效果,结果显示补充维生素D可使龋齿风险降低约47%。另有研究发现[8],无龋儿童拥有理想25(OH)D水平的概率是患龋儿童的2倍; 重度幼儿龋病儿童维生素D缺乏的发生概率接近普通儿童的3倍。

骨化二醇水平不足与牙周炎

牙周炎与多种疾病相关,包括糖尿病、缺血性卒中、心血管疾病、类风湿关节炎、炎症性肠病和精神应激等[2]。已有大量研究显示维生素D对牙周健康的影响,一项欧洲专家共识指出[9],维生素D营养状态不足会损害牙周健康与口腔功能。维生素D浓度越低,牙周组织破坏越重、牙周炎分期越重、牙齿丢失风险越高[10-13]。排除心血管病、糖尿病的健康人群,确诊牙周炎的患者同样伴随更低的维生素D水平 [14-15]。研究发现[16],与牙周健康者相比,牙周炎患者唾液维生素D水平更低,同时炎症生物标志物(IL‑35、IL‑17A、TGF)更高,证实局部处于炎症微环境。目前,临床前与临床研究均支持:维生素D通过其代谢通路参与牙周炎发病,影响牙齿矿化密度,且血清维生素D水平与牙周炎严重程度呈负相关[17-19]。

骨化二醇水平不足与口腔肿瘤

维生素D可能在部分口腔恶性肿瘤的发生、进展中发挥作用,但仍有大量内容有待探究。一项病例对照研究提示[20],维生素D缺乏会升高食管、口腔、口咽鳞状细胞癌风险,在重度吸烟、大量饮酒人群中风险更为突出。另有研究观察到癌前病变、口腔癌组织维生素D受体表达上调;晚期口腔肿瘤患者补充维生素D可显著降低治疗相关毒副反应,减少并发症,提升生活质量[21]。未来研究需要进一步阐明维生素D缺乏和口腔癌发病的关系,以及维生素D对肿瘤药物治疗毒性的改善价值。

如何安全高效提升骨化二醇水平?

维生素D缺乏和口腔疾病高度相关,会提升牙齿发育缺陷、龋齿、牙周炎以及各类口腔治疗失败的风险。维持适宜的25(OH)D水平,有利于口腔发育与口腔健康。当前,能够提升25(OH)D水平的维生素D制剂种类较多,包括膳食营养性维生素D和前体储存性维生素D,各制剂作用特点和不良反应存在较大差异,见下表。

不同种类维生素D制剂的临床作用特点

骨化二醇是活性维生素D的激素前体,水溶性更强,无需经肝脏羟化,可快速提升25 (OH) D水平。同等剂量的骨化二醇提升25(OH)D的效率是维生素D3的2-5 倍,尤其适用于需要快速提升25(OH)D水平的人群[22]。骨化二醇包括速释制剂和缓释制剂。速释骨化二醇 (immediate release calcifediol, IRC)虽可纠正维生素D缺乏,但会激活维生素D的分解代谢通路,且会干扰钙磷代谢[23,24]。缓释骨化二醇(extended release calcifediol, ERC)可平稳、持续、有效提升25(OH)D水平,且对维生素D分解代谢、钙磷平衡及FGF-23干扰极小,为广大维生素D不足和缺乏人群提供了全面均衡的补充方案[25]。

References

中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物的临床应用共识 (2025版). 中华骨质疏松和骨矿盐疾病杂志. 2025; 18(5): 497-517.

João Botelho, Vanessa Machado, Luís Proença, et al. Vitamin D Deficiency and Oral Health: A Comprehensive Review. Nutrients. 2020; 12(5): 1471.

Brian L Foster, Francisco H Nociti Jr, Martha J Somerman. The rachitic tooth. Endocr Rev. 2014; 35(1):1-34.

Lori D'Ortenzio, Bonnie Kahlon, Taylor Peacock, et al. The rachitic tooth: Refining the use of interglobular dentine in diagnosing vitamin D deficiency. Int J Paleopathol. 2018; 22: 101-108.

Susan G Reed, Delia Voronca, Jeanette S Wingate, et al. Prenatal vitamin D and enamel hypoplasia in human primary maxillary central incisors: a pilot study. Pediatr Dent J. 2017; 27(1): 21-28.

Pia Elisabeth Nørrisgaard, Dorte Haubek, Jan Kühnisch, et al. Association of High-Dose Vitamin D Supplementation During Pregnancy With the Risk of Enamel Defects in Offspring: A 6-Year Follow-up of a Randomized Clinical Trial. JAMA Pediatr. 2019; 173(10): 924-930.

Philippe P Hujoel. Vitamin D and dental caries in controlled clinical trials: systematic review and meta-analysis. Nutr Rev. 2013; 71(2): 88-97.

Robert J Schroth, Jeremy A Levi, Elizabeth A Sellers, et al. Vitamin D status of children with severe early childhood caries: a case-control study. BMC Pediatr. 2013; 13: 174.

Iain L C Chapple, Philippe Bouchard, Maria Grazia Cagetti, et al. Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017; 44 Suppl 18: S39-S51.

Thomas Dietrich, Kaumudi J Joshipura, Bess Dawson-Hughes, et al. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr. 2004; 80(1): 108-113.

Y Zhan, S Samietz, B Holtfreter, et al. Prospective Study of Serum 25-hydroxy Vitamin D and Tooth Loss. J Dent Res. 2014; 93(7): 639-644.

Amy E Millen, Kathleen M Hovey, Michael J LaMonte, et al. Plasma 25-hydroxyvitamin D concentrations and periodontal disease in postmenopausal women. J Periodontol. 2013; 84(9): 1243-1256.

G N Antonoglou, M Knuuttila, O Niemelä, et al. Low serum level of 1,25(OH)2 D is associated with chronic periodontitis. J Periodontal Res. 2015; 50(2): 274-280.

Anshuka A Agrawal, Abhay P Kolte, Rajashri A Kolte, et al. Evaluation and comparison of serum vitamin D and calcium levels in periodontally healthy, chronic gingivitis and chronic periodontitis in patients with and without diabetes mellitus - a cross-sectional study. Acta Odontol Scand. 2019; 77(8): 592-599.

Gaetano Isola, Angela Alibrandi, Ernesto Rapisarda, et al. Association of vitamin D in patients with periodontitis: A cross-sectional study. J Periodontal Res. 2020; 55(5): 602-612.

Erica Costantini, Bruna Sinjari, Francesca Piscopo, et al. Evaluation of Salivary Cytokines and Vitamin D Levels in Periodontopathic Patients. Int J Mol Sci. 2020; 21(8): 2669.

Anne Marie Uwitonze, Julienne Murererehe, Marie Claire Ineza, et al. Effects of vitamin D status on oral health. J Steroid Biochem Mol Biol. 2018; 175: 190-194.

Eglė Jagelavičienė, Inga Vaitkevičienė, Dovilė Šilingaitė, et al. The Relationship between Vitamin D and Periodontal Pathology. Medicina (Kaunas). 2018; 54(3): 45.

Akshay Anand, Suyash Singh, Abhinav A Sonkar, et al. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol (Pozn). 2017; 21(2): 145-151.

L Lipworth, M Rossi, J K McLaughlin, et al. Dietary vitamin D and cancers of the oral cavity and esophagus. Ann Oncol. 2009; 20(9): 1576-1581.

Akshay Anand, Suyash Singh, Abhinav A Sonkar, et al. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol (Pozn). 2017; 21(2): 145-151.

Roberto Cesareo, Roberto Attanasio, Marco Caputo, et al. Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients. 2018; 10(5): 546.

Martin Petkovich, Glenville Jones. CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens. 2011; 20(4): 337-344.

Martin Petkovich, Joel Melnick, Jay White, et al. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. J Steroid Biochem Mol Biol. 2015; 148: 283-289.

Stuart M Sprague, Paul W Crawford, Joel Z Melnick, et al. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol. 2016; 44(4): 316-325.